We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
After serving as Gilead Sciences’ CEO for 20 years, John C. Martin announced Friday that he is stepping down and will assume the role of executive chairman of the company.